Skip to Content

Join the 'IV Catheter Clot' group to help and get support from people like you.

IV Catheter Clot News

U.S. Hospitals Halve Catheter Infection Rates: Review

Posted 15 days ago by Drugs.com

MONDAY, Nov. 21, 2016 – U.S. hospitals have cut in half the number of potentially deadly bloodstream infections linked to so-called central-line catheters since 2008. But, too many critically ill patients are still exposed to dangerous bacteria, a new review from Consumer Reports contends. Central-line catheters deliver medication, nutrients and fluids to a patient through one intravenous line (IV). While often lifesaving, these lines can also harbor germs when not handled properly, and then transmit those germs directly into the bloodstream of a patient, the Consumer Reports researchers said. Once the bacteria have a foothold in the body, they can spread quickly and widely, and cause organ failure. And some of these bacteria are particularly virulent because they are resistant to antibiotics. Among the most dangerous: methicillin-resistant Staphylococcus aureus (MRSA). To gauge how ... Read more

Related support groups: Infections, Bacterial Infection, IV Catheter Clot, Chronic Central Venous Catheterization

Clot Retrieval Device Approval Expanded

Posted 6 Sep 2016 by Drugs.com

TUESDAY, Sept. 6, 2016 – Two similar devices that help doctors retrieve blood clots and avoid potential disability among stroke victims have been approved for new uses by the U.S. Food and Drug Administration. The Trevo devices were first cleared in 2012 to help people who could not be given the clot-busting drug t-PA. The devices, when fully expanded to up to six millimeters in diameter, allow doctors to grip a blood clot inside a vessel and remove it via catheter or sheath, the FDA said in a news release. The new approval expands the devices' use to include a broader group of patients, the agency said. Stroke kills some 130,000 people in the United States annually, making it the 5th-leading cause of death, according to the U.S. Centers for Disease Control and Prevention. Potential risks of the devices include failure to retrieve a clot, device breakage and blood vessel damage. The ... Read more

Related support groups: Bleeding Disorder, Ischemic Stroke, Transient Ischemic Attack, Ischemic Stroke - Prophylaxis, Coagulation Defects and Disorders, IV Catheter Clot

Placing Large Catheter in Vein Under Collarbone Best, Study Finds

Posted 23 Sep 2015 by Drugs.com

WEDNESDAY, Sept. 23, 2015 – For patients in intensive care units who need a catheter so they can receive medications easily, one placed in the vein under the collarbone appears to lower the risk of bloodstream infections and clots, a new study finds. The researchers reported that it lowered those risks by two to three times when compared to catheters placed in the large vein in the groin or in the jugular vein in the neck. "There has been an ongoing controversy about where to place these large catheters that would have the least risk of life-threatening infections," said senior researcher Dr. Leonard Mermel, from Lifespan in Providence, R.I. These infections are usually caused by bacteria on the skin that cling to the catheter as it is inserted and find their way into the bloodstream, he explained. In this setting, a catheter is a long tube that is inserted into the body so medicines ... Read more

Related support groups: Infections, IV Catheter Clot, Chronic Central Venous Catheterization

Stroke Drug May Prevent Dialysis Catheter Infections

Posted 27 Jan 2011 by Drugs.com

WEDNESDAY, Jan. 26 – Replacing the commonly used blood-thinner heparin with a clot-dissolving stroke drug in dialysis catheters once a week may reduce the incidence of catheter malfunctions and infections, according to new research. Recombinant tissue plasminogen activator (rt-PA) is a medication normally used to break up stroke-causing clots in the brain. However, when researchers used this drug in dialysis catheters instead of heparin after one of three dialysis sessions a week, the rate of catheter malfunction dropped from 35 percent to 20 percent. In addition, the infection rate was 4.5 percent in the group that received rt-PA compared to 13 percent for the group treated only with heparin. "With rt-PA we could reduce the rates of catheter malfunction by about 50 percent and infections by almost two-thirds," said the study's lead author, Dr. Brenda Hemmelgarn, an associate professor ... Read more

Related support groups: IV Catheter Clot

New Anti-Clotting Treatment Urged for Cancer Patients

Posted 13 Feb 2009 by Drugs.com

FRIDAY, Feb. 13 – The blood thinner warfarin does not reduce catheter-related blood clots in cancer patients, so new treatments are needed to prevent this complication, says a U.K. study. About 50 percent of cancer patients develop venous thromboembolism, which can be caused by a number of factors, including the use of central venous catheters to deliver infusional chemotherapy, according to background information in the study. The use of warfarin with the catheters to prevent clotting is controversial because there's no clear evidence that it's effective. The study included 1,590 cancer patients at 68 centers who were receiving chemotherapy through central venous catheters. The patients were randomly selected to receive either no warfarin, a fixed dose of 1 milligram of warfarin a day or dose-adjusted warfarin daily. Overall, rates of catheter-related blood clots were the same (6 ... Read more

Related support groups: IV Catheter Clot

Ask a Question

Further Information

Related Drug Support Groups

Cathflo Activase, alteplase